Paul versus Baerveldt 350 glaucoma drainage implants: One-year comparative analysis.

Area of Science:

• Ophthalmology
• Glaucoma Management
• Surgical Implants

Background:

• Glaucoma is a leading cause of irreversible blindness worldwide.
• Glaucoma drainage devices are crucial for managing refractory intraocular pressure (IOP).
• Comparing novel and established implants is essential for optimizing surgical outcomes.

Purpose of the Study:

• To evaluate and compare the efficacy and safety of the Paul glaucoma implant (PGI) versus the Baerveldt 350 glaucoma implant (BGI).
• To assess outcomes over a 1-year follow-up period in patients with uncontrolled IOP.

Main Methods:

• Retrospective comparison of 27 patients receiving PGI with 29 eyes receiving BGI.
• Intervention involved implantation in the anterior or posterior chamber for uncontrolled IOP.
• Key outcomes included IOP reduction, medication use, success rates, and complications.

Main Results:

• Both PGI and BGI achieved significant IOP reduction (P < 0.001).
• No significant differences in mean IOP or medication usage at 1 year.
• BGI had lower failure rates (7%) and higher complete success rates (56%) compared to PGI (18% failure, 32% success).
• Hypertensive phases were more common with BGI (32%) than PGI (19%).
• Complication rates and postoperative visual acuity were comparable between groups.

Conclusions:

• The Paul glaucoma implant (PGI) and Baerveldt 350 glaucoma implant (BGI) demonstrate comparable efficacy and safety profiles after one year.
• Both devices are effective in reducing intraocular pressure in glaucoma patients.